Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Gasum on acquisition of Swedish Biogas International
Mandate

Vinge advises Gasum on acquisition of Swedish Biogas International

January 05, 2017

Vinge advises Gasum Oy on its acquisition 100% of the shares of the Swedish biogas producer Swedish Biogas International AB. The transaction makes Gasum the biggest producer of biogas in the Nordic countries. Through the acquisition, five biogas plants located in Jordberga, Katrineholm, Lidköping and Örebro as well as a majority shareholding in a production plant located in Västerås, Sweden, are transferred to Gasum’s ownership. Swedish Biogas International also has a 50% shareholding in Vadsbo Biogas.

Vinge’s team comprised primarily Peter Sundgren and Gustav Tengblad.

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

 Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024